Pentraxin 3 (PTX3), which is produced by endothelial cells in response to various inflammatory events, has been proposed as an indicator of inflammatory vascular injury and as a biomarker of vasculitis in SLE and other diseases such as sepsis, septic shock, and preeclampsia. Here, PTX3 is linked to systemic lupus erythematosus.